BEGIN:VCALENDAR VERSION:2.0 METHOD:PUBLISH CALSCALE:GREGORIAN PRODID:-//WordPress - MECv7.3.1//EN X-ORIGINAL-URL:https://www.newenglandhemophilia.org/ X-WR-CALNAME:New England Hemophilia Association X-WR-CALDESC:New England Hemophilia Association REFRESH-INTERVAL;VALUE=DURATION:PT1H X-PUBLISHED-TTL:PT1H X-MS-OLK-FORCEINSPECTOROPEN:TRUE BEGIN:VEVENT CLASS:PUBLIC UID:MEC-2bd388f731f26312bfc0fe30da009595@newenglandhemophilia.org DTSTART:20210121T000000Z DTEND:20210121T010000Z DTSTAMP:20231117T173100Z CREATED:20231117 LAST-MODIFIED:20231117 PRIORITY:5 SEQUENCE:0 TRANSP:OPAQUE SUMMARY:Educational Webinar: A Novel Treatment for Bleeding Disorders DESCRIPTION:This was the first event in our 2021 Webinar Wednesday Series. Throughout this series, we will be hosting a live webinar every other Wednesday evening at 7 PM about various topics of interest and importance in our community. To watch one of our previous webinars, click here ( https://www.newenglandhemophilia.org/resources/webinars/ ).\n \nAbout This Webinar\nThis webinar was held on Wednesday, January 20 at 7 PM.\nCreating the next generation of therapies for hemophilia has had its share of successes and challenges. During this webinar, President & CEO of Sigilon Therapeutics, Rogerio Vivaldi, M.D., MBA, discussed the history of what has been done, what lessons have been learned, and how Sigilon is using the power of the cell as a potential therapy for people with bleeding disorders.\nThis webinar was supported by Sigilon Therapeutics. \n URL:https://www.newenglandhemophilia.org/events/educational-webinar-a-novel-treatment-for-bleeding-disorders/ ATTACH;FMTTYPE=image/png:/wp-content/uploads/2020/12/TTest-tube.png END:VEVENT END:VCALENDAR